Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 50%High 0 · 0%

Mifepristone (600 mg) plus prostaglandin vs mifepristone (200 mg) plus prostaglandin

Failure to achieve complete abortion · women undergoing first trimester abortion

Mifepristone (600 mg) plus prostaglandin showed no clear difference in failure to achieve complete abortion compared with mifepristone (200 mg) plus prostaglandin (moderate certainty).

1 finding from 1 review

Medical methods for first trimester abortion 2022 · Cochrane Headline outcomes only
RR 1.07 [0.87, 1.33]
4 studies · 3494 participants
Moderate

Mifepristone (600 mg) plus prostaglandin vs mifepristone (200 mg) plus prostaglandin

Nausea · women undergoing first trimester abortion

Mifepristone (600 mg) plus prostaglandin showed no clear difference in nausea compared with mifepristone (200 mg) plus prostaglandin (moderate certainty).

1 finding from 1 review

Medical methods for first trimester abortion 2022 · Cochrane Headline outcomes only
RR 1.02 [0.95, 1.09]
2 studies · 2432 participants
Moderate

Mifepristone (600 mg) plus prostaglandin vs mifepristone (200 mg) plus prostaglandin

Women's dissatisfaction with the procedure · women undergoing first trimester abortion

The review found no eligible studies for this question.

1 finding from 1 review

Medical methods for first trimester abortion 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mifepristone (600 mg) plus prostaglandin vs mifepristone (200 mg) plus prostaglandin

Blood transfusion · women undergoing first trimester abortion

The review found no eligible studies for this question.

1 finding from 1 review

Medical methods for first trimester abortion 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found